Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
about
Antiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice.Cytomegalovirus and herpes simplex virus effect on the prognosis of mechanically ventilated patients suspected to have ventilator-associated pneumonia.Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent miceCytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.Active cytomegalovirus infection in patients with septic shock.Right place, right time: the evolving role of herpesvirus infection as a "second hit" in idiopathic pulmonary fibrosisCytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome.Sepsis and cytomegalovirus: foes or conspirators?Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodiesCytomegalovirus reactivation in critically ill immunocompetent patients.Cytomegalovirus infection in critically ill patients: a systematic review.A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes.Herpes simplex activation prolongs recovery from severe burn injury and increases bacterial infection risk.Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection.Effect of Ganciclovir on IL-6 Levels Among Cytomegalovirus-Seropositive Adults With Critical Illness: A Randomized Clinical Trial.Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.Expanding role of cytomegalovirus as a human pathogen.Viral-Reactivated Pneumonia during Mechanical Ventilation: Is There Need for Antiviral Treatment?Cytomegalovirus reactivation and associated outcome of critically ill patients with severe sepsis.Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells.Impaired polyfunctionality of CD8+ T cells in severe sepsis patients with human cytomegalovirus reactivation.The pathogenetic role of CMV in intensive care unit patients: the uncertainity remainsAntiviral prophylaxis of cytomegalovirus reactivation in immune competent patients-the jury remains out.Cytomegalovirus in the intensive care unit: pathogen or passenger?Cytomegalovirus is still in intensive care.Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: pro.Cytomegalovirus esophagitis precipitated with immunosuppression in elderly giant cell arteritis patients.Association Between Cytomegalovirus Reactivation and Clinical Outcomes in Immunocompetent Critically Ill Patients: A Systematic Review and Meta-Analysis.Virological and immunological features of active cytomegalovirus infection in nonimmunosuppressed patients in a surgical and trauma intensive care unit.The Potential Harm of Cytomegalovirus Infection in Immunocompetent Critically Ill Children.
P2860
Q33695591-01AF7499-D727-4DD3-80B3-6C8D0EB8EE75Q34510887-CFB25A43-7677-41FF-9712-AF18E7DF3740Q35024244-4113EF2B-226F-4C43-8E44-B0CCB5B5BFD6Q35086196-0F49D9B3-B8BA-4694-B842-92F755002D2BQ35792205-D4FC347D-FC85-4690-AE4A-5AD2C867857CQ35850237-B8CA94B3-D6A8-4459-B1F6-6EDB91A6C98FQ36564294-4A3755EE-1F9E-4F71-AADB-FDA32FB6512AQ37055722-4DF5254D-5B3C-4F4B-8755-874FCDEC2346Q37196366-8C7D107C-FFD3-4A60-AF24-4BE911A833B2Q37414600-1CD54F0D-B055-40AC-8305-10B90B116CBFQ37482179-89201419-2393-4DE0-8DE1-168C593DDCA7Q37764937-759A290C-917F-46A3-975D-FB619EAE810FQ37955615-722C5ED0-7E24-4969-8DBA-C917AE9B7272Q38044678-B5929D04-6AD5-4C30-8000-B68E3B6D8B9DQ38371830-869B41C5-B6C0-4063-A7C1-3E549D809BF2Q38377602-3C570EAD-0EE3-4E4B-A4B0-2572076D7161Q38673038-0933FC2C-8123-4719-81B4-F31C81DEC03BQ38978367-79DCC481-2890-4281-88CA-EA0ADA0504F0Q39199695-D9DA98C0-65FA-4142-9C02-BC5EF29EBFA6Q39860663-A8A1173B-8267-4B0D-9978-923337599581Q41993154-08903796-4C29-448D-B338-6B8EF3E3EB43Q42342023-01DD93F1-DCFC-4ED6-B7CE-5E2AE5532404Q42357340-A646F9BC-B539-4E6D-8C40-1A680259D36BQ42630114-32640014-3D08-4A41-A186-AA31F3A3E4EBQ49975048-8594BB1C-8396-4997-993F-9D3F1DD63C93Q51798856-C3087ADD-238D-451F-8901-8338DB79CA36Q51872881-E16B5ED7-8163-4C05-81F5-A32342ED817DQ53840220-87AB4A44-28A6-404A-A97F-57C7B320D22CQ54422897-07887884-730D-423B-8894-C9F8981CE454Q55261466-3CC93F8D-BC88-4232-96A2-7E0E76E22708
P2860
Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
@ast
Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
@en
type
label
Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
@ast
Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
@en
prefLabel
Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
@ast
Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
@en
P2093
P2860
P1476
Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.
@en
P2093
Charles H Cook
Daniel D Sedmak
Larry C Martin
Ronald M Ferguson
Scott Jewell
Yingxue Zhang
P2860
P304
P356
10.1097/01.CCM.0000201876.11059.05
P407
P577
2006-03-01T00:00:00Z